カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の経口用抗生物質市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Oral Antibiotics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19478）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19478
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：105
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の経口用抗生物質市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

経口用抗生物質市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の経口用抗生物質の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

経口用抗生物質市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ベータラクタム＆ベータラクタマーゼ阻害剤、キノロン、マクロライド

用途別セグメントは次のように区分されます。
・気道感染症、歯科治療

世界の経口用抗生物質市場の主要な市場プレーヤーは以下のとおりです。
・Abbott Laboratories、Allergan、F.Hoffmann-La Roche、GlaxoSmithKline、Merck and Corporation、Mylan、Novartis、Pfizer、Sanofi、Teva Pharmaceutical Industries

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、経口用抗生物質製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な経口用抗生物質メーカーの企業概要、2019年～2022年までの経口用抗生物質の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な経口用抗生物質メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別経口用抗生物質の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの経口用抗生物質の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での経口用抗生物質市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および経口用抗生物質の産業チェーンを掲載しています。
・第13、14、15章では、経口用抗生物質の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 経口用抗生物質の概要
- 種類別分析（2017年vs2021年vs2028年）：ベータラクタム＆ベータラクタマーゼ阻害剤、キノロン、マクロライド
- 用途別分析（2017年vs2021年vs2028年）：気道感染症、歯科治療
- 世界の経口用抗生物質市場規模・予測
- 世界の経口用抗生物質生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Abbott Laboratories、Allergan、F.Hoffmann-La Roche、GlaxoSmithKline、Merck and Corporation、Mylan、Novartis、Pfizer、Sanofi、Teva Pharmaceutical Industries
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ベータラクタム＆ベータラクタマーゼ阻害剤、キノロン、マクロライド
・用途別分析2017年-2028年：気道感染症、歯科治療
・経口用抗生物質の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・経口用抗生物質のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・経口用抗生物質のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・経口用抗生物質の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・経口用抗生物質の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Oral Antibiotics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oral Antibiotics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Respiratory Tract Infection accounting for % of the Oral Antibiotics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Beta Lactam and Beta Lactamase Inhibitors segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oral Antibiotics include Abbott Laboratories, Allergan, F.Hoffmann-La Roche, GlaxoSmithKline, and Merck and Corporation, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oral Antibiotics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Beta Lactam and Beta Lactamase Inhibitors
Quinolone
Macrolide
Market segment by Application can be divided into
Respiratory Tract Infection
Dental Therapy
The key market players for global Oral Antibiotics market are listed below:
Abbott Laboratories
Allergan
F.Hoffmann-La Roche
GlaxoSmithKline
Merck and Corporation
Mylan
Novartis
Pfizer
Sanofi
Teva Pharmaceutical Industries
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Antibiotics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Antibiotics, with price, sales, revenue and global market share of Oral Antibiotics from 2019 to 2022.
Chapter 3, the Oral Antibiotics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Antibiotics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oral Antibiotics market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Antibiotics.
Chapter 13, 14, and 15, to describe Oral Antibiotics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Oral Antibiotics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Antibiotics Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Beta Lactam and Beta Lactamase Inhibitors
1.2.3 Quinolone
1.2.4 Macrolide
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Antibiotics Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Respiratory Tract Infection
1.3.3 Dental Therapy
1.4 Global Oral Antibiotics Market Size & Forecast
1.4.1 Global Oral Antibiotics Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oral Antibiotics Sales in Volume (2017-2028)
1.4.3 Global Oral Antibiotics Price (2017-2028)
1.5 Global Oral Antibiotics Production Capacity Analysis
1.5.1 Global Oral Antibiotics Total Production Capacity (2017-2028)
1.5.2 Global Oral Antibiotics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Antibiotics Market Drivers
1.6.2 Oral Antibiotics Market Restraints
1.6.3 Oral Antibiotics Trends Analysis
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Oral Antibiotics Product and Services
2.1.4 Abbott Laboratories Oral Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Oral Antibiotics Product and Services
2.2.4 Allergan Oral Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 F.Hoffmann-La Roche
2.3.1 F.Hoffmann-La Roche Details
2.3.2 F.Hoffmann-La Roche Major Business
2.3.3 F.Hoffmann-La Roche Oral Antibiotics Product and Services
2.3.4 F.Hoffmann-La Roche Oral Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Oral Antibiotics Product and Services
2.4.4 GlaxoSmithKline Oral Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck and Corporation
2.5.1 Merck and Corporation Details
2.5.2 Merck and Corporation Major Business
2.5.3 Merck and Corporation Oral Antibiotics Product and Services
2.5.4 Merck and Corporation Oral Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Oral Antibiotics Product and Services
2.6.4 Mylan Oral Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Oral Antibiotics Product and Services
2.7.4 Novartis Oral Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Oral Antibiotics Product and Services
2.8.4 Pfizer Oral Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Oral Antibiotics Product and Services
2.9.4 Sanofi Oral Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Teva Pharmaceutical Industries
2.10.1 Teva Pharmaceutical Industries Details
2.10.2 Teva Pharmaceutical Industries Major Business
2.10.3 Teva Pharmaceutical Industries Oral Antibiotics Product and Services
2.10.4 Teva Pharmaceutical Industries Oral Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Oral Antibiotics Breakdown Data by Manufacturer
3.1 Global Oral Antibiotics Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oral Antibiotics Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oral Antibiotics
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Antibiotics Manufacturer Market Share in 2021
3.4.2 Top 6 Oral Antibiotics Manufacturer Market Share in 2021
3.5 Global Oral Antibiotics Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oral Antibiotics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oral Antibiotics Market Size by Region
4.1.1 Global Oral Antibiotics Sales in Volume by Region (2017-2028)
4.1.2 Global Oral Antibiotics Revenue by Region (2017-2028)
4.2 North America Oral Antibiotics Revenue (2017-2028)
4.3 Europe Oral Antibiotics Revenue (2017-2028)
4.4 Asia-Pacific Oral Antibiotics Revenue (2017-2028)
4.5 South America Oral Antibiotics Revenue (2017-2028)
4.6 Middle East and Africa Oral Antibiotics Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Oral Antibiotics Sales in Volume by Type (2017-2028)
5.2 Global Oral Antibiotics Revenue by Type (2017-2028)
5.3 Global Oral Antibiotics Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Oral Antibiotics Sales in Volume by Application (2017-2028)
6.2 Global Oral Antibiotics Revenue by Application (2017-2028)
6.3 Global Oral Antibiotics Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Oral Antibiotics Sales by Type (2017-2028)
7.2 North America Oral Antibiotics Sales by Application (2017-2028)
7.3 North America Oral Antibiotics Market Size by Country
7.3.1 North America Oral Antibiotics Sales in Volume by Country (2017-2028)
7.3.2 North America Oral Antibiotics Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Oral Antibiotics Sales by Type (2017-2028)
8.2 Europe Oral Antibiotics Sales by Application (2017-2028)
8.3 Europe Oral Antibiotics Market Size by Country
8.3.1 Europe Oral Antibiotics Sales in Volume by Country (2017-2028)
8.3.2 Europe Oral Antibiotics Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Oral Antibiotics Sales by Type (2017-2028)
9.2 Asia-Pacific Oral Antibiotics Sales by Application (2017-2028)
9.3 Asia-Pacific Oral Antibiotics Market Size by Region
9.3.1 Asia-Pacific Oral Antibiotics Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oral Antibiotics Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Oral Antibiotics Sales by Type (2017-2028)
10.2 South America Oral Antibiotics Sales by Application (2017-2028)
10.3 South America Oral Antibiotics Market Size by Country
10.3.1 South America Oral Antibiotics Sales in Volume by Country (2017-2028)
10.3.2 South America Oral Antibiotics Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oral Antibiotics Sales by Type (2017-2028)
11.2 Middle East & Africa Oral Antibiotics Sales by Application (2017-2028)
11.3 Middle East & Africa Oral Antibiotics Market Size by Country
11.3.1 Middle East & Africa Oral Antibiotics Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oral Antibiotics Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Oral Antibiotics and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oral Antibiotics
12.3 Oral Antibiotics Production Process
12.4 Oral Antibiotics Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oral Antibiotics Typical Distributors
13.3 Oral Antibiotics Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Oral Antibiotics Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Oral Antibiotics Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Laboratories Major Business
Table 5. Abbott Laboratories Oral Antibiotics Product and Services
Table 6. Abbott Laboratories Oral Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Allergan Basic Information, Manufacturing Base and Competitors
Table 8. Allergan Major Business
Table 9. Allergan Oral Antibiotics Product and Services
Table 10. Allergan Oral Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. F.Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 12. F.Hoffmann-La Roche Major Business
Table 13. F.Hoffmann-La Roche Oral Antibiotics Product and Services
Table 14. F.Hoffmann-La Roche Oral Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 16. GlaxoSmithKline Major Business
Table 17. GlaxoSmithKline Oral Antibiotics Product and Services
Table 18. GlaxoSmithKline Oral Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merck and Corporation Basic Information, Manufacturing Base and Competitors
Table 20. Merck and Corporation Major Business
Table 21. Merck and Corporation Oral Antibiotics Product and Services
Table 22. Merck and Corporation Oral Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Mylan Basic Information, Manufacturing Base and Competitors
Table 24. Mylan Major Business
Table 25. Mylan Oral Antibiotics Product and Services
Table 26. Mylan Oral Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Novartis Basic Information, Manufacturing Base and Competitors
Table 28. Novartis Major Business
Table 29. Novartis Oral Antibiotics Product and Services
Table 30. Novartis Oral Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Major Business
Table 33. Pfizer Oral Antibiotics Product and Services
Table 34. Pfizer Oral Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Sanofi Basic Information, Manufacturing Base and Competitors
Table 36. Sanofi Major Business
Table 37. Sanofi Oral Antibiotics Product and Services
Table 38. Sanofi Oral Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 40. Teva Pharmaceutical Industries Major Business
Table 41. Teva Pharmaceutical Industries Oral Antibiotics Product and Services
Table 42. Teva Pharmaceutical Industries Oral Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Oral Antibiotics Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Oral Antibiotics Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Oral Antibiotics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Oral Antibiotics Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Oral Antibiotics Production Site of Key Manufacturer
Table 48. Oral Antibiotics New Entrant and Capacity Expansion Plans
Table 49. Oral Antibiotics Mergers & Acquisitions in the Past Five Years
Table 50. Global Oral Antibiotics Sales by Region (2017-2022) & (K Units)
Table 51. Global Oral Antibiotics Sales by Region (2023-2028) & (K Units)
Table 52. Global Oral Antibiotics Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Oral Antibiotics Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Oral Antibiotics Sales by Type (2017-2022) & (K Units)
Table 55. Global Oral Antibiotics Sales by Type (2023-2028) & (K Units)
Table 56. Global Oral Antibiotics Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Oral Antibiotics Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Oral Antibiotics Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Oral Antibiotics Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Oral Antibiotics Sales by Application (2017-2022) & (K Units)
Table 61. Global Oral Antibiotics Sales by Application (2023-2028) & (K Units)
Table 62. Global Oral Antibiotics Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Oral Antibiotics Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Oral Antibiotics Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Oral Antibiotics Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Oral Antibiotics Sales by Country (2017-2022) & (K Units)
Table 67. North America Oral Antibiotics Sales by Country (2023-2028) & (K Units)
Table 68. North America Oral Antibiotics Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Oral Antibiotics Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Oral Antibiotics Sales by Type (2017-2022) & (K Units)
Table 71. North America Oral Antibiotics Sales by Type (2023-2028) & (K Units)
Table 72. North America Oral Antibiotics Sales by Application (2017-2022) & (K Units)
Table 73. North America Oral Antibiotics Sales by Application (2023-2028) & (K Units)
Table 74. Europe Oral Antibiotics Sales by Country (2017-2022) & (K Units)
Table 75. Europe Oral Antibiotics Sales by Country (2023-2028) & (K Units)
Table 76. Europe Oral Antibiotics Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Oral Antibiotics Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Oral Antibiotics Sales by Type (2017-2022) & (K Units)
Table 79. Europe Oral Antibiotics Sales by Type (2023-2028) & (K Units)
Table 80. Europe Oral Antibiotics Sales by Application (2017-2022) & (K Units)
Table 81. Europe Oral Antibiotics Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Oral Antibiotics Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Oral Antibiotics Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Oral Antibiotics Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Oral Antibiotics Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Oral Antibiotics Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Oral Antibiotics Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Oral Antibiotics Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Oral Antibiotics Sales by Application (2023-2028) & (K Units)
Table 90. South America Oral Antibiotics Sales by Country (2017-2022) & (K Units)
Table 91. South America Oral Antibiotics Sales by Country (2023-2028) & (K Units)
Table 92. South America Oral Antibiotics Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Oral Antibiotics Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Oral Antibiotics Sales by Type (2017-2022) & (K Units)
Table 95. South America Oral Antibiotics Sales by Type (2023-2028) & (K Units)
Table 96. South America Oral Antibiotics Sales by Application (2017-2022) & (K Units)
Table 97. South America Oral Antibiotics Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Oral Antibiotics Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Oral Antibiotics Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Oral Antibiotics Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Oral Antibiotics Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Oral Antibiotics Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Oral Antibiotics Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Oral Antibiotics Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Oral Antibiotics Sales by Application (2023-2028) & (K Units)
Table 106. Oral Antibiotics Raw Material
Table 107. Key Manufacturers of Oral Antibiotics Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Oral Antibiotics Typical Distributors
Table 111. Oral Antibiotics Typical Customers
List of Figures
Figure 1. Oral Antibiotics Picture
Figure 2. Global Oral Antibiotics Revenue Market Share by Type in 2021
Figure 3. Beta Lactam and Beta Lactamase Inhibitors
Figure 4. Quinolone
Figure 5. Macrolide
Figure 6. Global Oral Antibiotics Revenue Market Share by Application in 2021
Figure 7. Respiratory Tract Infection
Figure 8. Dental Therapy
Figure 9. Global Oral Antibiotics Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Oral Antibiotics Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Oral Antibiotics Sales (2017-2028) & (K Units)
Figure 12. Global Oral Antibiotics Price (2017-2028) & (US$/Unit)
Figure 13. Global Oral Antibiotics Production Capacity (2017-2028) & (K Units)
Figure 14. Global Oral Antibiotics Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Oral Antibiotics Market Drivers
Figure 16. Oral Antibiotics Market Restraints
Figure 17. Oral Antibiotics Market Trends
Figure 18. Global Oral Antibiotics Sales Market Share by Manufacturer in 2021
Figure 19. Global Oral Antibiotics Revenue Market Share by Manufacturer in 2021
Figure 20. Oral Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Oral Antibiotics Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Oral Antibiotics Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Oral Antibiotics Sales Market Share by Region (2017-2028)
Figure 24. Global Oral Antibiotics Revenue Market Share by Region (2017-2028)
Figure 25. North America Oral Antibiotics Revenue (2017-2028) & (USD Million)
Figure 26. Europe Oral Antibiotics Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Oral Antibiotics Revenue (2017-2028) & (USD Million)
Figure 28. South America Oral Antibiotics Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Oral Antibiotics Revenue (2017-2028) & (USD Million)
Figure 30. Global Oral Antibiotics Sales Market Share by Type (2017-2028)
Figure 31. Global Oral Antibiotics Revenue Market Share by Type (2017-2028)
Figure 32. Global Oral Antibiotics Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Oral Antibiotics Sales Market Share by Application (2017-2028)
Figure 34. Global Oral Antibiotics Revenue Market Share by Application (2017-2028)
Figure 35. Global Oral Antibiotics Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Oral Antibiotics Sales Market Share by Type (2017-2028)
Figure 37. North America Oral Antibiotics Sales Market Share by Application (2017-2028)
Figure 38. North America Oral Antibiotics Sales Market Share by Country (2017-2028)
Figure 39. North America Oral Antibiotics Revenue Market Share by Country (2017-2028)
Figure 40. United States Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Oral Antibiotics Sales Market Share by Type (2017-2028)
Figure 44. Europe Oral Antibiotics Sales Market Share by Application (2017-2028)
Figure 45. Europe Oral Antibiotics Sales Market Share by Country (2017-2028)
Figure 46. Europe Oral Antibiotics Revenue Market Share by Country (2017-2028)
Figure 47. Germany Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Oral Antibiotics Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Oral Antibiotics Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Oral Antibiotics Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Oral Antibiotics Revenue Market Share by Region (2017-2028)
Figure 56. China Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Oral Antibiotics Sales Market Share by Type (2017-2028)
Figure 63. South America Oral Antibiotics Sales Market Share by Application (2017-2028)
Figure 64. South America Oral Antibiotics Sales Market Share by Country (2017-2028)
Figure 65. South America Oral Antibiotics Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Oral Antibiotics Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Oral Antibiotics Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Oral Antibiotics Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Oral Antibiotics Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Oral Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Oral Antibiotics in 2021
Figure 77. Manufacturing Process Analysis of Oral Antibiotics
Figure 78. Oral Antibiotics Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のカルバペネム系抗生物質市場2022年：市場規模予測（～2028年）
  • 世界のエルシニア症治療用抗生物質市場2022年：市場規模予測（～2028年）
  • 世界のペプチド抗生物質無菌注射剤市場2022年：市場規模予測（～2028年）
  • 世界のテトラサイクリン系抗生物質市場2022年：市場規模予測（～2028年）
  • 世界の吸入抗生物質市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19478 )"世界の経口用抗生物質市場2022年：市場規模予測（～2028年）" (英文：Global Oral Antibiotics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。